These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10981255)

  • 1. Pentoxifylline for sickle-cell disease.
    Sherer JT; Glover PH
    Ann Pharmacother; 2000 Sep; 34(9):1070-4. PubMed ID: 10981255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
    Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
    J Med; 1979; 10(6):445-56. PubMed ID: 299453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
    Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
    J Med; 1988; 19(2):67-88. PubMed ID: 3171402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.
    Ambrus JL; Ambrus CM; Bannerman R; Sills RH; Meky NN
    J Med; 1984; 15(5-6):385-407. PubMed ID: 6100377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Stiff red cell syndrome". A review of the treatment of sickle cell disease with pentoxifylline.
    Ambrus JL; Reddington TM; Meky NN; Conway J
    J Med; 1993; 24(1):1-9. PubMed ID: 8501400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pharmacotherapeutic approaches for the management of sickle cell disease.
    Torres L; Conran N
    Expert Opin Pharmacother; 2019 Feb; 20(2):173-186. PubMed ID: 30499731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline.
    Poflee VW; Gupta OP; Jain AP; Jajoo UN
    J Assoc Physicians India; 1991 Aug; 39(8):608-9. PubMed ID: 1814876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV
    J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anemia. Pathophysiological role of increased intracorpuscular calcium and changes during treatment with pentoxifylline.
    Manrique R
    Ric Clin Lab; 1987; 17(4):355-62. PubMed ID: 3438670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
    Ambrus JL; Ambrus CM; Gastpar H
    J Med; 1979; 10(5):339-45. PubMed ID: 119023
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results.
    Seiffge D; Berthold R; Berthold F
    Klin Wochenschr; 1983 Nov; 61(22):1159-60. PubMed ID: 6656178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study: an open clinical trial of pentoxiphylline in patients with painful sickle cell crises.
    Khosla AA; Chintu C
    East Afr Med J; 1984 Nov; 61(11):829-36. PubMed ID: 6399024
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of homozygous sickle cell disease with pentoxifylline.
    Sacerdote A
    J Natl Med Assoc; 1999 Aug; 91(8):466-70. PubMed ID: 12656436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis.
    Chiao TB; Lee AJ
    Ann Pharmacother; 2005 Mar; 39(3):516-22. PubMed ID: 15701781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of vasoocclusive pain events in sickle cell disease.
    Ellison AM; Shaw K
    Pediatr Emerg Care; 2007 Nov; 23(11):832-8; quiz 838-41. PubMed ID: 18007218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.